Sage Therapeutics to Present at J.P. Morgan Healthcare Conference on Monday, January 13, 2020
December 23 2019 - 6:30AM
Business Wire
Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company
committed to developing novel therapies with the potential to
transform the lives of people with debilitating disorders of the
brain, today announced that the Company will present at the J.P.
Morgan 2020 Healthcare Conference in San Francisco, Calif. on
Monday, January 13, 2020 at 1:30 p.m. PST (4:30 p.m. EST), followed
by a Q&A session.
A live webcast of the presentation and Q&A session can be
accessed on the investor page of Sage's website at
investor.sagerx.com. A replay of the webcast will also be archived
for up to 30 days on Sage's website following the conference.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company committed to developing novel therapies
with the potential to transform the lives of people with
debilitating disorders of the brain. We are pursuing new pathways
with the goal of improving brain health, and our depression,
neurology and neuropsychiatry franchise programs aim to change how
brain disorders are thought about and treated. Our mission is to
make medicines that matter so people can get better, sooner. For
more information, please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191223005007/en/
Investor Contact Matthew Calistri 617-914-2635
matthew.calistri@sagerx.com
Media Contact Alexis Smith 617-588-3740
alexis.smith@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2023 to Apr 2024